| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $95M | ||
| $91M |
Buys | $98,106 | 3 | 100 |
Sells | $0 | 0 | 0 |
| Duran Felipe | Chief Financial Officer | 1 | $50,132 | 0 | $0 | $50,132 |
| Brenner Martin | See Remarks | 1 | $24,919 | 0 | $0 | $24,919 |
| Banjak Marc | Chief Legal Officer | 1 | $23,055 | 0 | $0 | $23,055 |
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas.
Over the last 12 months, insiders at iBio, Inc. have bought $98,106 and sold $0 worth of iBio, Inc. stock.
On average, over the past 5 years, insiders at iBio, Inc. have bought $376,550 and sold $33,225 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Duran Felipe (Chief Financial Officer) — $50,132. Brenner Martin (See Remarks) — $24,919. Banjak Marc (Chief Legal Officer) — $23,055.
The last purchase of 13,934 shares for transaction amount of $23,055 was made by Banjak Marc (Chief Legal Officer) on 2026‑03‑26.
| 2026-03-26 | Banjak Marc | Chief Legal Officer | 13,934 0.0839% | $1.65 | $23,055 | +6.90% | ||
| 2026-03-19 | Duran Felipe | Chief Financial Officer | 24,835 0.1512% | $2.02 | $50,132 | -10.48% | ||
| 2026-03-19 | Brenner Martin | See Remarks | 12,336 0.0752% | $2.02 | $24,919 | -10.48% | ||
| 2025-01-10 | Parada Antonio Bernardino Guimaraes | director | 183,823 2.1264% | $2.72 | $499,999 | -60.00% | ||
| 2025-01-10 | Arkowitz David | director | 18,382 0.2126% | $2.72 | $49,999 | -60.00% | ||
| 2025-01-10 | Brenner Martin | See Remarks | 9,191 0.1063% | $2.72 | $25,000 | -60.00% | ||
| 2025-01-10 | Duran Felipe | Chief Financial Officer | 9,191 0.1063% | $2.72 | $25,000 | -60.00% | ||
| 2025-01-10 | Banjak Marc | Chief Legal Officer | 9,191 0.1063% | $2.72 | $25,000 | -60.00% | ||
| 2025-01-10 | Sender Gary | director | 9,191 0.1063% | $2.72 | $25,000 | -60.00% | ||
| 2025-01-10 | Clark William D | director | 1,838 0.0213% | $2.72 | $4,999 | -60.00% | ||
| 2023-11-01 | Sale | Brenner Martin | See Remarks | 4,881 0.0175% | $0.27 | $1,296 | -63.98% | |
| 2023-10-03 | Sale | Brenner Martin | See Remarks | 5,267 0.0187% | $0.30 | $1,592 | -67.58% | |
| 2023-10-02 | Sale | Brenner Martin | See Remarks | 4,215 0.0154% | $0.31 | $1,311 | -68.63% | |
| 2023-08-28 | Sale | Brenner Martin | See Remarks | 5,011 0.0211% | $0.31 | $1,529 | -68.36% | |
| 2023-07-27 | Sale | Brenner Martin | See Remarks | 4,515 0.0337% | $0.51 | $2,308 | -78.92% | |
| 2023-07-12 | Sale | Brenner Martin | See Remarks | 47,020 0.3517% | $0.59 | $27,521 | -81.02% | |
| 2023-06-21 | Sale | Brenner Martin | See Remarks | 4,184 0.0322% | $0.68 | $2,849 | -81.57% | |
| 2023-05-22 | Sale | Brenner Martin | See Remarks | 4,182 0.032% | $0.94 | $3,910 | -71.51% | |
| 2023-04-24 | Sale | Brenner Martin | See Remarks | 4,382 0.0338% | $1.20 | $5,258 | -75.42% | |
| 2023-03-23 | Sale | Brenner Martin | See Remarks | 5,213 0.0411% | $2.13 | $11,112 | -84.88% |
| Duran Felipe | Chief Financial Officer | 35974 0.2278% | $65,472.68 | 2 | 0 | <0.0001% |
| Brenner Martin | See Remarks | 30652 0.1941% | $55,786.64 | 2 | 11 | <0.0001% |
| Banjak Marc | Chief Legal Officer | 25000 0.1583% | $45,500.00 | 2 | 0 | <0.0001% |
| Eastern Capital LTD | 10 percent owner | 8629693 54.6547% | $15.71M | 6 | 6 | |
| DESANTIS CARL | 10 percent owner | 5751143 36.4239% | $10.47M | 6 | 25 | |
| KAY E GERALD | 10 percent owner | 4119803 26.0921% | $7.5M | 0 | 5 | |
| MCKEY JOHN D JR | director | 968284 6.1325% | $1.76M | 2 | 6 | |
| Maddux Randy Joe | Chief Operating Officer | 271757 1.7211% | $494,597.74 | 0 | 1 | |
| Lutz Robert Matthew | See Remarks | 207375 1.3134% | $377,422.50 | 0 | 1 | |
| Parada Antonio Bernardino Guimaraes | director | 183823 1.1642% | $334,557.86 | 1 | 0 | <0.0001% |
| ERWIN ROBERT L | President | 108108 0.6847% | $196,756.56 | 0 | 2 | |
| Arkowitz David | director | 18382 0.1164% | $33,455.24 | 1 | 0 | <0.0001% |
| Sender Gary | director | 9191 0.0582% | $16,727.62 | 1 | 0 | <0.0001% |
| Clark William D | director | 1838 0.0116% | $3,345.16 | 1 | 0 | <0.0001% |
| DART KENNETH BRYAN | 10 percent owner | 1 0% | $1.82 | 1 | 0 | |
| Mullaney James P. | Chief Financial Officer | 0 0% | $0 | 0 | 1 |
$8,253,997 | 122 | -53.40% | $19.66M | |
$18,815,063 | 62 | -6.39% | $21.22M | |
$6,204,522 | 45 | 1.91% | $24.66M | |
$94,610,184 | 33 | -23.48% | $18.03M | |
$95,303,339 | 30 | -13.78% | $34.69M | |
$2,983,776 | 25 | -16.47% | $33.5M | |
$523,320 | 24 | 94.37% | $34.12M | |
$241,165 | 22 | -16.72% | $33.88M | |
$351,813 | 19 | 21.51% | $32.46M | |
$91,696,644 | 18 | -4.72% | $19.06M | |
$13,486,672 | 11 | 82.26% | $31.95M | |
$13,595,542 | 9 | -16.74% | $18.61M | |
$189,648 | 9 | -52.20% | $32.31M | |
iBio, Inc. (IBIO) | $654,995 | 7 | -60.00% | $28.74M |
$8,470,804 | 6 | -13.28% | $20.98M | |
$26,254,149 | 5 | 49.97% | $30.38M | |
$100,266 | 2 | 3.17% | $25.89M | |
$16,526,031 | 2 | -0.85% | $25.77M | |
$30,190 | 1 | -42.39% | $30.51M |
| Increased Positions | 38 | +122.58% | 14M | +406.13% |
| Decreased Positions | 11 | -35.48% | 2M | -48.44% |
| New Positions | 26 | New | 12M | New |
| Sold Out Positions | 8 | Sold Out | 2M | Sold Out |
| Total Postitions | 58 | +87.1% | 16M | +357.69% |
| Lynx1 Capital Management Lp | $2,133.00 | 4.8% | 1.06M | -482,676 | -31.37% | 2025-09-30 |
| Ikarian Capital, Llc | $1,247.00 | 2.81% | 617,327 | +17,414 | +2.9% | 2025-09-30 |
| Ameriprise Financial Inc | $974.00 | 2.19% | 482,300 | +482,300 | New | 2025-09-30 |
| Opaleye Management Inc. | $758.00 | 1.71% | 375,000 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $554.00 | 1.25% | 274,070 | +130,209 | +90.51% | 2025-09-30 |
| Boothbay Fund Management, Llc | $357.00 | 0.8% | 176,862 | +17,414 | +10.92% | 2025-09-30 |
| Geode Capital Management, Llc | $306.00 | 0.69% | 151,309 | +39,008 | +34.73% | 2025-09-30 |
| Citadel Advisors Llc | $267.00 | 0.6% | 131,958 | +131,958 | New | 2025-09-30 |
| Two Sigma Securities, Llc | $91.00 | 0.21% | 45,079 | +16,517 | +57.83% | 2025-09-30 |
| Susquehanna International Group, Llp | $90.00 | 0.2% | 44,471 | +44,471 | New | 2025-09-30 |